Thoma Bravo agreed to acquire a majority of the company. MedeAnalytics’ previous backers Bain Capital Integral Investors and Emergence Capital partners will retain minority stakes.
“MedeAnalytics represents an outstanding investment opportunity in the healthcare data analytics sector,” said Scott Crabill, managing partner at Thoma Bravo.
MedeAnalytics serves more than 1,500 healthcare organizations globally.
More articles on finance issues:
RCM tip of the day: Mitigate spikes in denial rates during the ICD-10 transition
Why HCA is taking the road less traveled when it comes to expansion
CDC: Fewer Americans avoiding medical care due to cost
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.